Antitumor effect of acridine orange under ultrasonic irradiation in vitro

超声辐照下吖啶橙的体外抗肿瘤作用

基本信息

  • 批准号:
    18591621
  • 负责人:
  • 金额:
    $ 1.96万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2006
  • 资助国家:
    日本
  • 起止时间:
    2006 至 2007
  • 项目状态:
    已结题

项目摘要

Background: Sonodynamic synergistic antitumor therapy is a promising new methodology for cancer treatment.Materials and Methods: To determine the antitumor effects of ultrasound (US) in the presence of acridine orange (AO), 1.0 μg/ml solution of AO was tested as a sonodynamic compound against sarcoma 180 cells in vitro.Results: After US irradiation at 2.0 W/cm^2 for 60 sec, the survival rate of tumor cells in the presence of AO was significantly lower than in its absence (p<0.001). In the AO-treated group, the tumor cells were mostly fragmented. When D-mannitol or L-histidine was used along with the AO, the survival rate of tumor cells after irradiation was significantly higher than that when AO alone was applied.Conclusion: AO could exhibit useful antitumor activity under US irradiation, and the generation of singlet oxygen and hydroxyl radicals is involved in the processes of tumor cell damage.
背景资料:声动力协同抗肿瘤治疗是一种很有前途的肿瘤治疗新方法。材料与方法:以吖啶橙子(AO)为声动力复合物,测定1.0 μg/ml AO对肉瘤180细胞的体外抗肿瘤作用。结果:AO与超声联合作用后,肿瘤细胞的生长速度明显加快。在2.0 W/cm ^2的超声照射60秒后,AO存在时肿瘤细胞的存活率显著低于AO不存在时(p<0.001)。在AO处理组中,肿瘤细胞大多是碎片。结论:AO在超声辐照下具有抗肿瘤活性,其作用机制可能与产生单线态氧和羟基自由基有关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Acridine Orange is one of the promising sonodynamic compounds-Clinical application for cases with huge soft tissue sarcoma
吖啶橙是一种有前景的声动力化合物——巨大软组织肉瘤的临床应用
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Okada K;Suzuki N;Chida S;Komori C
  • 通讯作者:
    Komori C
Acridine Orange is one of the promising sonodynamic compounds-Clinical application for cases with huge soft tissue sarcoma-
吖啶橙是一种有前途的声动力化合物-巨大软组织肉瘤病例的临床应用-
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Okada K;Suzuki N;Chida S;Komori C.
  • 通讯作者:
    Komori C.
Antitumor effect of acridine orange under ultrasonic irradiation in vitro.
  • DOI:
  • 发表时间:
    2007-11
  • 期刊:
  • 影响因子:
    2
  • 作者:
    Norio Suzuki;K. Okada;Shuichi Chida;Chiyo Komori;Y. Shimada;Toshio Suzuki
  • 通讯作者:
    Norio Suzuki;K. Okada;Shuichi Chida;Chiyo Komori;Y. Shimada;Toshio Suzuki
Acridine Orange is one of the promising sonodynamic compounds - Clinical application for cases with huge soft tissue sarcoma-
吖啶橙是一种有前途的声动力化合物 - 巨大软组织肉瘤病例的临床应用 -
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Okada;K;Suzuki;N;Chida;S;Komori;C.
  • 通讯作者:
    C.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OKADA Kyoji其他文献

OKADA Kyoji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OKADA Kyoji', 18)}}的其他基金

Exercise induced expressions of transforming factors in skeletal muscle, fat tissue, vessel walls, and hippocampus.
运动诱导骨骼肌、脂肪组织、血管壁和海马体中转化因子的表达。
  • 批准号:
    23500834
  • 财政年份:
    2011
  • 资助金额:
    $ 1.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Ultrasound therapy for soft tissue sarcoma with new quinolone antibiotics as a sonodynamic compound
使用新型喹诺酮抗生素作为声动力化合物对软组织肉瘤进行超声治疗
  • 批准号:
    16591469
  • 财政年份:
    2004
  • 资助金额:
    $ 1.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Enhanced antitumor effect of ultrasound in the presence of piroxicam in a mouse airpouch model.
在小鼠气袋模型中,在吡罗昔康存在下,超声波增强了抗肿瘤作用。
  • 批准号:
    11671414
  • 财政年份:
    1999
  • 资助金额:
    $ 1.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of prevention of lung metastasis or sarcoma by tumor-associated macrophage
肿瘤相关巨噬细胞预防肺转移或肉瘤的机制
  • 批准号:
    09671467
  • 财政年份:
    1997
  • 资助金额:
    $ 1.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An novel hematoporphyrin-anticancer drug conjugate for a therapy of lung metastasis of sarcoma.
一种新型血卟啉-抗癌药物缀合物,用于治疗肉瘤肺转移。
  • 批准号:
    07671566
  • 财政年份:
    1995
  • 资助金额:
    $ 1.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

ERI: Non-Contact Ultrasound Generation and Detection for Tissue Functional Imaging and Biomechanical Characterization
ERI:用于组织功能成像和生物力学表征的非接触式超声波生成和检测
  • 批准号:
    2347575
  • 财政年份:
    2024
  • 资助金额:
    $ 1.96万
  • 项目类别:
    Standard Grant
CAREER: Hydrogen-Bonded Organic Frameworks Nanoparticles for Ultrasound-Activated, Genetically-Targeted Neuromodulation
职业:用于超声激活、基因靶向神经调节的氢键有机框架纳米颗粒
  • 批准号:
    2340964
  • 财政年份:
    2024
  • 资助金额:
    $ 1.96万
  • 项目类别:
    Continuing Grant
I-Corps: Translation Potential of Simultaneous Musculoskeletal Assessment with Real-Time Ultrasound
I-Corps:实时超声同步肌肉骨骼评估的转化潜力
  • 批准号:
    2413735
  • 财政年份:
    2024
  • 资助金额:
    $ 1.96万
  • 项目类别:
    Standard Grant
ICF: Enhancing Blood-Brain Barrier Opening with Ultrasound and Microwaves for Targeted Drug Delivery
ICF:利用超声波和微波增强血脑屏障开放以实现靶向药物输送
  • 批准号:
    MR/Z503848/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.96万
  • 项目类别:
    Research Grant
ERI: Biological Effects of Low-Frequency, Low-Intensity Ultrasound on Endothelial Cell and Macrophage Co-Culture
ERI:低频、低强度超声对内皮细胞和巨噬细胞共培养的生物学效应
  • 批准号:
    2347558
  • 财政年份:
    2024
  • 资助金额:
    $ 1.96万
  • 项目类别:
    Standard Grant
CAREER: Developing Ultrasound-Programmable 3D-Printed Biomaterials for Spatiotemporal Control of Gene Delivery
职业:开发用于基因传递时空控制的超声波可编程 3D 打印生物材料
  • 批准号:
    2339254
  • 财政年份:
    2024
  • 资助金额:
    $ 1.96万
  • 项目类别:
    Continuing Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 1.96万
  • 项目类别:
    Standard Grant
Phase-change nanodroplets for ultrasound based theranostics
用于超声治疗诊断的相变纳米液滴
  • 批准号:
    2899729
  • 财政年份:
    2024
  • 资助金额:
    $ 1.96万
  • 项目类别:
    Studentship
Multi-site and state-dependent effects of Transcranial Ultrasound Stimulation on brain function and cognition
经颅超声刺激对脑功能和认知的多部位和状态依赖性影响
  • 批准号:
    BB/Y001494/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.96万
  • 项目类别:
    Research Grant
CAREER: Super-Resolution 3D Ultrasound Imaging of Brain Activity
职业:大脑活动的超分辨率 3D 超声成像
  • 批准号:
    2237309
  • 财政年份:
    2023
  • 资助金额:
    $ 1.96万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了